(Q43570316)

24 November 2017

Selective estrogen receptor modulators for the chemoprevention of prostate cancer (English)

1 reference

24 November 2017

Steiner MS

1

1 reference

24 November 2017

Raghow S

series ordinal

2

1 reference

24 November 2017

Neubauer BL

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

57

1 reference

24 November 2017

68-72

1 reference

24 November 2017

4 Suppl 1

1 reference

24 November 2017

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Is radical prostatectomy primarily a surgical debulking procedure?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Chemoprevention of prostate cancer: concepts and strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Functional Analysis of a Novel Estrogen Receptor- Isoform

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Nuclear receptor coactivators and corepressors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Generation and reproductive phenotypes of mice lacking estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

ER beta: identification and characterization of a novel human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Estrogen receptor expression in prostate cancer and premalignant prostatic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Estrogen receptors in the human male prostatic urethra and prostate in prostatic cancer and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Hormonal regulation of the androgen receptor expression in human prostatic cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

The induction of prostatic hypertrophy in the dog with androstanediol

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Long-term Effects of Perinatal Exposure to Sex Steroids and Diethylstilbestrol on the Reproductive System of Male Mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Prostatic dysplasia associated with increased expression of c-myc in neonatally estrogenized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

The periurethral zone of the prostate of the cynomolgus monkey is the most sensitive prostate part for an estrogenic stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Diet and its preventive role in prostatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Naturally occurring oestrogens in foods--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Selective oestrogen receptor modulation: molecular pharmacology for the millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Prevention of prostate-related cancers in Lobund-Wistar rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Prostate cancer in a transgenic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Role of peptide growth factors in the prostate: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Prostate cancer cell growth inhibition by tamoxifen is associated with inhibition of protein kinase C and induction of p21(waf1/cip1)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Tamoxifen, serum lipoproteins and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

Introductory remarks: Development of chemopreventive agents for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900944-4

7 January 2021

10.1016/S0090-4295(00)00944-4

Identifiers

DOI

1 reference

24 November 2017

1 reference